Cart summary

You have no items in your shopping cart.

RPI-1

SKU: orb1223165

Description

RPI-1 is an ATP-dependent RET kinase inhibitor. Oral treatment with RPI-1 caused growth arrest or regression in 81% treated tumors. Following treatment suspension, tumor inhibition was maintained (51%, P<0.05, 100 days) and cures were achieved in 2/11 mice. In vivo effects of RPI-1 were reflected in activation of BAD, cleavage of caspases, apoptotic DNA fragmentation and inhibition of VEGF production observed in in vitro RPI-1-treated TT cells..

Images & Validation

Key Properties

CAS Number269730-03-2
MW297.31
Purity>98% (HPLC)
FormulaC17H15NO4
SMILESCOc1c(cc2c(c1)/C(=C/c1ccc(cc1)O)/C(=O)N2)OC
TargetAChR
SolubilityIn Vitro: DMSO : 125 mg/mL (420.44 mM)

Bioactivity

In Vivo
RPI-1 (50, 100 mg/kg; p.o. ; twice a day for 10 days) inhibits the tumor growth of TT xenografts by 81%. Animal model: 8-to 11-week-old female athymic nude CD-1 mice (bearing TT cells). Dosage: 50, 100 mg/kg. Administration: p.o. ; twice a day for 10 days. Result: A dose-dependent effect on tumor growth was observed, with a dose of 2*50 mg/kg/day resulting in less tumor weight inhibition than the 2*100 mg/kg/day dose after 10 days of treatment.
In Vitro
TPC-1 cells are sensitive to the growth inhibitory effect of RPI-1 with an IC50 of 5.1 μM, following 72 hours of treatment. RPI-1 (7.5-60 μM) inhibits Ret/Ptc1 autophosphorylation in TPC-1 cells. RPI-1 inhibitory effects in the TPC-1 cell culture conditions lead to inhibition of pathways involving JNK2 and AKT. The RPI-1 IC50 value for cell proliferation is 3.6 μM in NIH3T3 cells expressing the Ret mutant compared with 16 μM in non-transfected NIH3T3 cells, and that for colony formation in soft agar was 2.4 μM and 26 μM in RET mutant-transfected and H-RAS-transfected NIH3T3 cells, respectively. In NIH3T3 cells expressing the Ret mutant, Ret protein and tyrosine phosphorylation were undetectable after 24 hours of RPI-1 treatment. In TT cells, RPI-1 inhibits proliferation, Ret tyrosine phosphorylation, Ret protein expression, and the activation of PLCgamma, ERKs and AKT.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

RPI-1 | RPI1 | RPI 1

Similar Products

  • rpi-1 Antibody [orb801744]

    ELISA,  WB

    Other

    Rabbit

    Polyclonal

    Unconjugated

    2 mg
  • RPI-1 [orb1305802]

    99.59% (May vary between batches)

    269730-03-2

    297.31

    C17H15NO4

    500 mg, 50 mg, 100 mg, 25 mg, 5 mg, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

RPI-1 (orb1223165)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

5 mg
$ 90.00
10 mg
$ 140.00
25 mg
$ 240.00
50 mg
$ 350.00
100 mg
$ 500.00
500 mg
$ 1,140.00